The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial

Taghi Badali ¹ , Sara Arefhosseini ¹ , Farnaz Rooholahzadegan ¹, Helda Tutunchi ² , Mehrangiz Ebrahimi-Mameghani ³ *

Cited by CrossRef: 1

1- Soroń-Lisik M, Więch P, Dąbrowski M. Beneficial Effect of Dietary Approaches to Stop Hypertension Diet Combined with Regular Physical Activity on Fat Mass and Anthropometric and Metabolic Parameters in People with Overweight and Obesity. Nutrients. 2024;16(18):3187 [Crossref]

2- Jurek J, Zablocka-Sowinska K, Clavero Mestres H, Reyes Gutiérrez L, Camaron J, Auguet T. The Impact of Dietary Interventions on Metabolic Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Comorbid Conditions, Including Obesity and Type 2 Diabetes. Nutrients. 2025;17(7):1257 [Crossref]

3- Jiang R, Wang T, Han K, Peng P, Zhang G, Wang H, Zhao L, Liang H, Lv X, Du Y. Impact of anti-inflammatory diets on cardiovascular disease risk factors: a systematic review and meta-analysis. Front Nutr. 2025;12 [Crossref]

4- Momeni S, Hajizadeh-Sharafabad F, Pashaei M. Adherence to the Dietary Approaches to Stop Hypertension diet was associated with the risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis of observational studies. Nutrition Research. 2025;137:14 [Crossref]

5- Hasan F, Singh A, Garcia A, Qadri S, Sattar H, Ali R, Ali H, Nguyen T, Mohan B, Contino K. Evaluating the impact of the Dietary Approaches to Stop Hypertension diet versus a calorie‐restricted diet on metabolic dysfunction‐associated steatotic liver disease: A meta‐analysis of randomized controlled trials. Hepatology Research. 2025;55(4):515 [Crossref]

6- Zare P, Bideshki M, Sohrabi Z, Behzadi M, Sartang M. Effect of Dietary Approaches to Stop Hypertension (DASH) diet on lipid profile in individuals with overweight/ obesity: A GRADE-assessed systematic review and meta-analysis of clinical trials. Nutrition, Metabolism and Cardiovascular Diseases. 2025;35(9):104057 [Crossref]